Membrane action and catecholamine release action of bretylium tosylate in normoxic and hypoxic canine Purkinje fibers.
Electrophysiologic effects of bretylium tosylate on transmembrane action potentials of canine Purkinje fibers were studied by microelectrode methods. Perfusion of this agent (20 mg/liter) prolonged the action potential duration and the effective refractory period, but did not alter the maximal diastolic potential, upstroke phase of the action potential and membrane responsiveness curve under normal oxygenation. With a hypoxic superfusion, the action potential amplitude, maximal diastolic potential, maximal rate of depolarization and action potential duration were all decreased. Subsequent addition of bretylium antagonized all these effects of hypoxia and restored the action potential variables to control values. However, similar effects of hypoxia observed in Purkinje fibers pretreated with reserpine were not reversed by bretylium except for a prolongation of repolarization. These results suggest that antiarrhythmic effects of bretylium in hypoxic or depressed myocardium are probably due to: 1) increased maximal rate of depolarization (and conduction velocity) caused by membrane hyperpolarization, and 2) prolongation of the effective refractory period. The first electrophysiologic action appears to depend on catecholamine release by bretylium, as hyperpolarization was not observed in reserpine-pretreated Purkinje fibers. The second effect may represent a direct membrane action.
D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D001949:Bretylium Compounds / Q000494:pharmacology*; D001950:Bretylium Tosylate / Q000494:pharmacology*; D002395:Catecholamines / Q000378:metabolism; D003971:Diastole / Q000187:drug effects; D004285:Dogs; D006329:Heart Conduction System / Q000187:drug effects*; D008839:Microelectrodes; D010100:Oxygen / Q000502:physiology; D011690:Purkinje Fibers / Q000187:drug effects* / Q000502:physiology; D012110:Reserpine / Q000494:pharmacology; D013997:Time Factors
D001949:Bretylium Compounds; D002395:Catecholamines; D001950:Bretylium Tosylate; D012110:Reserpine; D010100:Oxygen